Oncology-Focused Biotech Receives Orphan Status for AML Drug

Source: Streetwise Reports   08/29/2018 An H.C. Wainwright & Co. report provided an update on two of this company’s four product candidates. In an Aug. 21, 2018, research note, Ram Selvaraju, an analyst with H.C. Wainwright [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.